BANKRUPTCY PLAYS

[I Like Bottom Fishing]

OSCIQ CHART 0.0480






















OSCIQ — Oscient Pharmaceuticals Corp.
Common Stock
Par Value: 0.10

Pink Sheets Limited
QuoteNewsChartsCompany InfoFilingsResearchShort InterestInsider Trans.

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=osciq#getCompanyInfo

Inside QuoteBest Bid Best Ask Time of Last Inside Change
0.048 (5000 shares) 0.05 (5000 shares) 2:39 PM

Trade Data / Last Trade 3:48 PMLast Sale 0.048 Change -0.002
% Change -4.00 Tick Down
Daily High 0.055 Daily Low 0.045
Opening Price 0.045 Volume 429,109
52 wk. High 1.14 52 wk. Low 0.016
Prev Close 0.05 Dividend 0.00
Yield 0.00 Beta Coefficient 0.54
Trade data delayed 15 minutes.
Refresh All Data
Contact Information Business Description
Oscient Pharmaceuticals Corp.
1000 Winter Street
Suite 2200
Waltham, MA 02451

http://www.oscient.com

* Phone: [phone]
* E-mail: [e-mail]

*
OTC Market Tier
Pink Sheets Limited
*
Primary SIC — Industry Classification
2834 - Pharmaceutical preparations

*
State Of Incorporation
MA
*
Jurisdiction Of Incorporation
United States

*
Company Officers
Philippe Maitre, CFO

*
SEC Reporting Status
SEC Reporting Company
*
CIK
0000356830
*
Fiscal Year End
12/31

*
Estimated Market Cap
$712,831 as of Oct 6, 2009
*
Outstanding Shares
14,256,628 as of Nov 3, 2008
*
Number of Share Holders of Record
1,264 as of Feb 6, 2008

*
Current Capital Change
shs decreased by 1 for 8 split
Pay Date: Nov 16, 2006

*
Company Notes
o Formerly=Genome Therapeutics Corp. until 4-04
o Formerly=Collaborative Research, Inc. until 9-94

*
Security Notes
o New Issue=2-82 1,300,000 shs at $11 by Merrill Lynch White Weld Capital Markets Group.
o Latest Addt'l Issue=5-83 1,600,000 shs at $10.50 by Merrill Lynch White Weld Capital Markets Group. et al.

*
Transfer Agent
Computershare Investor Services LLC
P.O. Box 43010
(150 Royall St. (Mail Stop 45-02-80))
Canton, MA 02021)
Providence, RI 02940-3010

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=osciq#getCompanyInfo

Short Interest SHO History

Date    	Short Interest	% Change	Avg. Daily Share Volume	Days to Cover	Split	New Issue 
 Sept 15, 2009	1,178,012	-0.54	961,760	1.22	No	No 
 Aug 31, 2009	1,184,450	-22.50	2,514,914	1.00	No	No 
 Aug 14, 2009	1,528,294	4.35	2,797,129	1.00	No	No 
 Jul 31, 2009	1,464,522	100.00	6,761,627	1.00	No	No 
 Jun 15, 2009	2,079,807	93.87	21,801,900	1.00	No	No 
 May 29, 2009	1,072,775	30.87	13,200,653	1.00	No	No 
 May 15, 2009	819,709	10.05	8,653,922	1.00	No	No 
 Apr 30, 2009	744,881	-13.32	3,319,052	1.00	No	No 
 Apr 15, 2009	859,350	15.16	1,749,584	1.00	No	No 
 Mar 31, 2009	746,248	12.60	821,485	1.00	No	No

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases.
Click here to update your company profile.
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=osciq#getCompanyInfo

I still believe this scenario hypothesis is still in play, but just how far will the MMi's take this bad boy down! OSCIQ Chart Play post by MaryKAustin One of the best around.

Please click here to view the OSCIQ chart play.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=42170115

God bless and always the best of trading.

Osciq chart play and level2 fighting a in house battle among the bankruptcy court bond holders & credit debtor's and the MM's being keep out of the lop or due they really know what is going on here i am for sure even thosee MM's have there bankruptcy spies eying and monitoring Osciq you think?





The osciq credit debtors and bond holders all want a peace of me osciq court conservator running as bond holders and other unpaid credit holders all want there money so where is all the money that went to osciq bankruptcy court in the recent sell of osciq drug sale to the companies listed below.
09/29/2009 (23:42 ET) India's Lupin buys US rights for cholesterol drug Antara - AsiaPulse Pte. Ltd. - Asia In Focus
09/29/2009 (22:58 ET) INDIA'S LUPIN BUYS US MKT RIGHTS OF ANTARA DRUG FOR US$38.61 MLN - AsiaPulse Pte. Ltd
09/09/2009 (07:10 ET) Cornerstone Wins Factive Rights - Zacks.com
09/05/2009 (13:07 ET) Cornerstone wins approval to acquire rights to Oscient's antibiotic drug - Datamonitor
09/03/2009 (08:01 ET) Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) - PR Newswire

Qsciq poker game among bankruptcy court bond holders credit holders MM's share holders all bluffing each other who will blink first here in this high steak game of confuse poker players.

Qsciq Political term oil and bankruptcy court conservator & debt creditors in a battle along with confuse greedy Osciq MM's not knowning witch way the wind is going to blow!

There can be only one winner here!

I could not find a osciq nut so i am drinking all of the osciq kool aid!